Cellectis S.A.
CLLS
$4.68
-$0.39-7.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 75.27M | 56.30M | 47.63M | 41.51M | 29.07M |
| Total Other Revenue | 7.28M | 7.14M | 7.12M | 7.71M | 6.97M |
| Total Revenue | 82.55M | 63.44M | 54.75M | 49.22M | 36.04M |
| Cost of Revenue | -- | -- | -- | -- | 737.00K |
| Gross Profit | 82.55M | 63.44M | 54.75M | 49.22M | 35.31M |
| SG&A Expenses | 19.92M | 19.88M | 18.68M | 19.09M | 18.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -911.00K | -932.00K | -1.24M | -849.00K | -192.00K |
| Total Operating Expenses | 108.96M | 108.65M | 107.59M | 108.77M | 114.00M |
| Operating Income | -26.41M | -45.22M | -52.84M | -59.56M | -77.95M |
| Income Before Tax | -34.84M | -58.54M | -60.27M | -36.76M | -84.99M |
| Income Tax Expenses | 514.00K | 455.00K | 262.00K | 0.00 | -508.00K |
| Earnings from Continuing Operations | -35.35 | -59.00 | -60.53 | -36.76 | -84.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 0.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 0.00 |
| Net Income | -35.35M | -59.00M | -60.53M | -36.76M | -84.48M |
| EBIT | -26.41M | -45.22M | -52.84M | -59.56M | -77.95M |
| EBITDA | -13.87M | -33.04M | -41.05M | -48.25M | -67.22M |
| EPS Basic | -0.36 | -0.59 | -0.63 | -0.37 | -1.07 |
| Normalized Basic EPS | -0.20 | -0.35 | -0.38 | -0.22 | -0.55 |
| EPS Diluted | -0.36 | -0.59 | -0.63 | -0.60 | -1.30 |
| Normalized Diluted EPS | -0.20 | -0.35 | -0.38 | -0.23 | -0.56 |
| Average Basic Shares Outstanding | 399.48M | 399.24M | 390.59M | 362.25M | 327.39M |
| Average Diluted Shares Outstanding | 400.86M | 399.24M | 390.59M | 393.53M | 358.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |